查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1761752

生物可吸收血管支架市场：全球产业分析、规模、份额、成长、趋势及预测（2025-2032）

Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球生物可吸收血管支架市场的综合报告。该报告全面评估了关键市场动态，包括市场驱动因素、趋势、机会和挑战，并深入分析了市场结构。研究报告提供了独家数据和统计数据，概述了 2025 年至 2032 年全球生物可吸收血管支架市场的预测成长轨迹。

关键见解

  • 生物可吸收血管支架市场规模（2025年）：3.144亿美元
  • 预计市场价值（2032年）：5.928亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：8.3%

生物可吸收血管支架市场研究范围：

生物可吸收血管支架 (BVS) 是用于治疗冠状动脉疾病的先进医疗设备，它透过向血管提供临时机械支撑同时在体内逐渐溶解。与传统金属支架不同，BVS 消除了与永久植入相关的长期併发症，例如晚期支架内血栓症。这些支架主要用于经经皮冠状动脉介入治疗 (PCI) 手术，越来越受到年轻患者和未来需要手术治疗的患者的青睐。 BVS 市场提供由聚乳酸 (PLA)、聚碳酸酯和其他生物可吸收聚合物製成的创新支架，以满足医院、心血管专科中心和门诊手术单位的需求。心血管疾病负担的加重、对下一代支架技术的需求不断增长以及向微创治疗的转变推动了市场扩张。

市场驱动因素：

全球生物可吸收血管支架市场受多种关键因素驱动，例如冠状动脉疾病盛行率的上升，尤其是在老化人口和高风险族群中。患者和医生越来越偏好使用可最大限度减少长期併发症的临时植入，这加速了生物可吸收血管支架（BVS）相对于传统支架的普及。改进的支架设计、更优的药物释放型性能以及更快的降解速度等技术进步正在改善临床疗效并促进产品创新。此外，主要市场监管部门的积极核准以及心血管研究投资的不断增加也支撑着市场的成长。由于医疗基础设施的改善以及人们对先进心血管治疗的认识不断提高，新兴经济体的生物可吸收血管支架的普及率也不断提高。

市场限制：

儘管生物可吸收血管支架市场成长潜力巨大，但其仍面临着许多挑战，例如设备成本高昂、报销政策有限以及对支架强度和长期疗效的担忧。早期临床试验提出了关于支架血栓症形成的安全问题，影响了其早期应用。严格的安全评估和复杂的核准途径等监管障碍，也为新参与企业带来了更大的市场挑战。此外，由于生物可吸收血管支架植入技术学习难度高，医师的犹豫可能会限制市场扩张，尤其是在欠发达地区。透过改善培训、提供透明的临床数据和经济高效的解决方案来解决这些问题，对于更广泛的应用至关重要。

市场机会：

生物可吸收血管支架市场蕴含着巨大的机会，这得益于材料科学、生物分解性药物传递系统以及精准介入心臟病学领域的技术创新。越来越多地使用先进的影像和诊断工具来支援支架的精准放置，从而提高了手术成功率和患者预后。医疗设备製造商与学术机构之间的合作正在推动性能更优、吸收速度更快的下一代支架的开发。随着医疗保健系统转向价值导向型护理，生物可吸收血管支架 (BVS) 有望降低长期併发症和再次手术率，使其成为一种经济高效的长期解决方案。新兴市场的扩张以及门诊 PCI 手术的日益增长趋势，为 BVS 提供了进一步的成长途径。

本报告探讨的关键问题

  • 推动全球生物可吸收血管支架市场成长的关键因素有哪些？
  • 哪些材料和技术引领 BVS 领域的创新？
  • 临床结果和病人安全如何影响整个医疗保健系统对 BVS 的采用？
  • 谁是生物可吸收血管支架市场的主要贡献者？他们采取了哪些策略措施来维持成长？
  • 全球 BVS 市场的新兴趋势和长期前景是什么？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 生物分解性聚合物和下一代支架设计的开发
    • 设计具有改进的生物相容性和可控降解速率的新型聚合物
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值洞察

  • 工具采用分析
  • 监管状况
  • 价值链分析
  • PESTLE分析
  • 波特五力分析

第四章 2025 年定价分析

  • 主要亮点
  • 影响实施成本的关键因素
  • 依公司类型进行定价分析

第五章全球生物可吸收血管支架市场展望

  • 主要亮点
    • 市场规模预测
    • 市场规模及年成长率
    • 绝对的商机
  • 市场规模及数量分析与预测
    • 2019-2024 年历史市场规模（百万美元）分析
    • 2025-2032年市场规模（百万美元）分析与预测
  • 全球生物可吸收血管支架市场展望：产品
    • 简介/主要发现
    • 2019 年至 2024 年历史市场规模（百万美元）和销售（单位）分析
    • 2025 年至 2032 年市场规模（百万美元）与销售量（单位）分析与预测
      • 金属生物可吸收血管支架
      • 聚合物生物可吸收血管支架
    • 市场吸引力分析：产品
  • 全球生物可吸收血管支架市场展望：应用
    • 简介/主要发现
    • 2019-2024 年历史市场规模（百万美元）分析
    • 2025-2032年市场规模（百万美元）分析与预测
      • 週边动脉
      • 冠状动脉
    • 市场吸引力分析：应用
  • 全球生物可吸收血管支架市场展望：最终用户
    • 简介/主要发现
    • 2019-2024 年历史市场规模（百万美元）分析
    • 2025-2032年市场规模（百万美元）分析与预测
      • 医院
      • 门诊手术中心
      • 心导管实验室
      • 其他的
    • 市场吸引力分析：最终用户

6. 全球生物可吸收血管支架市场展望-地区

  • 主要亮点
  • 2019 年至 2024 年市场规模与数量趋势分析
  • 2025-2032 年市场规模及数量分析及预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

7. 北美生物可吸收血管支架市场展望

8. 欧洲生物可吸收血管支架市场展望

第九章东亚生物可吸收血管支架市场展望

10.南亚和大洋洲生物可吸收血管支架市场展望

第11章拉丁美洲生物可吸收血管支架市场展望

12. 中东和非洲生物可吸收血管支架市场展望

第十三章竞争格局

  • 2025年市场占有率分析
  • 市场结构
    • 市场竞争加剧图
    • 竞争仪錶板
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Meril Life Sciences Pvt. Ltd.
    • Zeus Company LLC
    • Biotronik
    • Abbott
    • MicroPort Scientific Corporation
    • Kyoto Medical
    • Elixir Medical
    • Cigna
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • REVA Medical

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP34715

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bioresorbable vascular scaffold market from 2025 to 2032.

Key Insights:

  • Bioresorbable Vascular Scaffold Market Size (2025E): USD 314.4 Million
  • Projected Market Value (2032F): USD 592.8 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds (BVS) are advanced medical devices used to treat coronary artery disease by providing temporary mechanical support to blood vessels while gradually dissolving in the body. Unlike traditional metallic stents, BVS eliminate the long-term complications associated with permanent implants, such as late stent thrombosis. These scaffolds are primarily utilized in percutaneous coronary intervention (PCI) procedures and are increasingly preferred for younger patients or those requiring future surgical options. The BVS market caters to hospitals, specialty cardiovascular centers, and ambulatory surgical units, offering innovative scaffolds made from polylactic acid (PLA), polycarbonate, and other bioresorbable polymers. Market expansion is driven by a growing burden of cardiovascular diseases, increased demand for next-generation stent technologies, and a shift toward minimally invasive treatment options.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the rising prevalence of coronary artery disease, especially in aging and high-risk populations. Increasing patient and physician preference for temporary implants that minimize long-term complications has accelerated the adoption of BVS over traditional stents. Technological advancements, including improved scaffold designs, enhanced drug-eluting properties, and faster degradation rates, are enhancing clinical outcomes and driving product innovation. Furthermore, favorable regulatory approvals in major markets and growing investment in cardiovascular research are supporting market growth. Emerging economies are also witnessing increased adoption due to the rise in healthcare infrastructure and awareness of advanced cardiovascular therapies.

Market Restraints:

Despite its strong growth potential, the bioresorbable vascular scaffold market faces challenges related to high device costs, limited reimbursement policies, and concerns about scaffold strength and long-term efficacy. Initial clinical trials raised safety issues regarding scaffold thrombosis, which impacted early adoption. Regulatory hurdles, including stringent safety evaluations and complex approval pathways, add to market entry challenges for new players. Additionally, physician hesitancy due to the steep learning curve associated with BVS implantation techniques can restrict market expansion, particularly in underdeveloped regions. Addressing these issues through improved training, transparent clinical data, and cost-effective solutions remains essential for broader acceptance.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant opportunities driven by innovations in material science, biodegradable drug delivery systems, and precision-based cardiovascular interventions. The increasing use of advanced imaging and diagnostic tools to support accurate scaffold placement enhances procedural success and patient outcomes. Collaborations between medical device manufacturers and academic institutions are fueling the development of next-generation scaffolds with optimized performance and faster resorption rates. As healthcare systems shift toward value-based care, the potential for reduced long-term complications and repeat procedures positions BVS as a cost-effective solution over time. Expansion into emerging markets and the rising trend of outpatient PCI procedures offer further growth avenues.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
  • Which materials and technologies are leading innovation in the BVS sector?
  • How are clinical outcomes and patient safety influencing the adoption of BVS across healthcare systems?
  • Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategic moves are they making to sustain growth?
  • What are the emerging trends and long-term prospects in the global BVS market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in R&D to enhance scaffold performance, reduce resorption time, and improve patient outcomes. Strategic partnerships with hospitals, research organizations, and cardiovascular societies facilitate clinical adoption and expand global reach. Additionally, market participants are prioritizing physician education programs, post-marketing surveillance studies, and expansion into high-growth regions to strengthen their market position and drive the transition toward bioresorbable technologies in cardiovascular care.

Key Companies Profiled:

  • Meril Life Sciences Pvt. Ltd.
  • Zeus Company LLC
  • Biotronik
  • Abbott
  • MicroPort Scientific Corporation
  • Kyoto Medical
  • Elixir Medical (MedImpact Healthcare Systems, Inc.)
  • Cigna
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • REVA Medical

Bioresorbable Vascular Scaffold Market Research Segmentation:

The bioresorbable vascular scaffold market encompasses a variety of materials, technologies, applications, and end-user segments tailored to the evolving needs of cardiovascular intervention.

By Product

  • Metal Bioresorbable Vascular Scaffold
  • Polymer Bioresorbable Vascular Scaffold

By Application

  • Peripheral Artery
  • Coronary Artery

By End-user

  • Hospitals
  • Ambulatory Care Centers
  • Cardiac Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. The development of biodegradable polymers and next-gen scaffold designs
    • 2.3.2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Tool Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Deployment Costs
  • 4.3. Pricing Analysis, By Enterprise Type

5. Global Bioresorbable Vascular Scaffold Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Metal Bioresorbable Vascular Scaffold
      • 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Peripheral Artery
      • 5.4.3.2. Coronary Artery
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Ambulatory Surgical Centers
      • 5.5.3.3. Cardiac Catheterization Labs
      • 5.5.3.4. Others
    • 5.5.4. Market Attractiveness Analysis: End-user

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End-user
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1.
      • 7.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 7.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Peripheral Artery
    • 7.5.2. Coronary Artery
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Cardiac Catheterization Labs
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End-user
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1.
      • 8.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 8.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025-2032
    • 8.5.1. Peripheral Artery
    • 8.5.2. Coronary Artery
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Cardiac Catheterization Labs
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End-user
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1.
      • 9.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 9.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Peripheral Artery
    • 9.5.2. Coronary Artery
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Cardiac Catheterization Labs
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End-user
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1.
      • 10.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 10.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Peripheral Artery
    • 10.5.2. Coronary Artery
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Cardiac Catheterization Labs
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End-user
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1.
      • 11.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 11.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Peripheral Artery
    • 11.5.2. Coronary Artery
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Surgical Centers
    • 11.6.3. Cardiac Catheterization Labs
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End-user
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1.
      • 12.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 12.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Peripheral Artery
    • 12.5.2. Coronary Artery
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Surgical Centers
    • 12.6.3. Cardiac Catheterization Labs
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meril Life Sciences Pvt. Ltd.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Deployments
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Zeus Company LLC
    • 13.3.3. Biotronik
    • 13.3.4. Abbott
    • 13.3.5. MicroPort Scientific Corporation
    • 13.3.6. Kyoto Medical
    • 13.3.7. Elixir Medical
    • 13.3.8. Cigna
    • 13.3.9. B. Braun Melsungen AG
    • 13.3.10. Boston Scientific Corporation
    • 13.3.11. REVA Medical

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations